OTC Pharmaceuticals in Russia

Datamonitor's OTC Pharmaceuticals in Russia industry profile is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

* Contains an executive summary and data on value, volume and/or segmentation

* Provides textual analysis of OTC Pharmaceuticals in Russia’s recent performance and future prospects

* Incorporates in-depth five forces competitive environment analysis and scorecards

* Includes a five-year forecast of OTC Pharmaceuticals in Russia

* The leading companies are profiled with supporting key financial metrics

* Supported by the key macroeconomic and demographic data affecting the market

Highlights

* Detailed information is included on market size, measured by both value and volume

* Five forces scorecards provide an accessible yet in depth view of the market’s competitive landscape

* Market shares are covered by manufacturer and/or brand

* Also features market breakdown by distribution channel

Why you should buy this report

* Spot future trends and developments

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research

Market Definition

The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria’s, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness).

For the purpose of this report Europe comprises Belgium, Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Romania, Russia, Spain, Sweden, Ukraine and the United Kingdom.

[Studien Infos ausblenden]

TABLE OF CONTENTS
EXECUTIVE SUMMARY 2
MARKET OVERVIEW 7
Market definition 7
Research highlights 8
Market analysis 9
MARKET VALUE 10
MARKET SEGMENTATION I 11
MARKET SEGMENTATION II 12
MARKET SHARE 13
FIVE FORCES ANALYSIS 14
Summary 14
Buyer power 16
Supplier power 17
New entrants 18
Substitutes 19
Rivalry 20
LEADING COMPANIES 21
Ranbaxy Laboratories Limited 21
Johnson & Johnson 25
Krka 30
MARKET DISTRIBUTION 34
MARKET FORECASTS 35
Market value forecast 35
MACROECONOMIC INDICATORS 36
APPENDIX 38
Methodology 38
Industry associations 39
Related Datamonitor research 39
Disclaimer 41
ABOUT DATAMONITOR 42
Premium Reports 42
Summary Reports 42
Datamonitor consulting 42

LIST OF TABLES
Table 1: Russia OTC pharmaceuticals market value: $ million, 2005–09 10
Table 2: Russia OTC pharmaceuticals market segmentation I:% share, by value, 2009 11
Table 3: Russia OTC pharmaceuticals market segmentation II: % share, by value, 2009 12
Table 4: Russia OTC pharmaceuticals market share: % share, by value, 2009 13
Table 5: Ranbaxy Laboratories Limited: key facts 21
Table 6: Ranbaxy Laboratories Limited: key financials ($) 22
Table 7: Ranbaxy Laboratories Limited: key financials (Rs.) 23
Table 8: Ranbaxy Laboratories Limited: key financial ratios 23
Table 9: Johnson & Johnson: key facts 25
Table 10: Johnson & Johnson: key financials ($) 27
Table 11: Johnson & Johnson: key financial ratios 28
Table 12: Krka: key facts 30
Table 13: Krka: key financials ($) 31
Table 14: Krka: key financials (€) 32
Table 15: Krka: key financial ratios 32
Table 16: Russia OTC pharmaceuticals market distribution: % share, by value, 2009 34
Table 17: Russia OTC pharmaceuticals market value forecast: $ million, 2009–14 35
Table 18: Russia size of population (million), 2005–09 36
Table 19: Russia gdp (constant 2000 prices, $ billion), 2005–09 36
Table 20: Russia gdp (current prices, $ billion), 2005–09 36
Table 21: Russia inflation, 2005–09 37
Table 22: Russia consumer price index (absolute), 2005–09 37
Table 23: Russia exchange rate, 2005–09 37

LIST OF FIGURES
Figure 1: Russia OTC pharmaceuticals market value: $ million, 2005–09 10
Figure 2: Russia OTC pharmaceuticals market segmentation I:% share, by value, 2009 11
Figure 3: Russia OTC pharmaceuticals market segmentation II: % share, by value, 2009 12
Figure 4: Russia OTC pharmaceuticals market share: % share, by value, 2009 13
Figure 5: Forces driving competition in the OTC pharmaceuticals market in Russia, 2009 14
Figure 6: Drivers of buyer power in the OTC pharmaceuticals market in Russia, 2009 16
Figure 7: Drivers of supplier power in the OTC pharmaceuticals market in Russia, 2009 17
Figure 8: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Russia, 2009 18
Figure 9: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Russia, 2009 19
Figure 10: Drivers of degree of rivalry in the OTC pharmaceuticals market in Russia, 2009 20
Figure 11: Ranbaxy Laboratories Limited: revenues & profitability 24
Figure 12: Ranbaxy Laboratories Limited: assets & liabilities 24
Figure 13: Johnson & Johnson: revenues & profitability 28
Figure 14: Johnson & Johnson: assets & liabilities 29
Figure 15: Krka: revenues & profitability 33
Figure 16: Krka: assets & liabilities 33
Figure 17: Russia OTC pharmaceuticals market distribution: % share, by value, 2009 34
Figure 18: Russia OTC pharmaceuticals market value forecast: $ million, 2009–14 35


[Inhaltsverzeichnis ausblenden]